These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33565152)

  • 1. Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells.
    Imamura K; Yada Y; Izumi Y; Morita M; Kawata A; Arisato T; Nagahashi A; Enami T; Tsukita K; Kawakami H; Nakagawa M; Takahashi R; Inoue H
    Ann Neurol; 2021 Jun; 89(6):1226-1233. PubMed ID: 33565152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
    Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
    Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS).
    Ma J; Feng B; Kong D; He J; Guo R; Amponsah AE; Zhang W; Zhang S; Lv F; Song Y; Liu A; Cui H
    Stem Cell Res; 2020 Apr; 44():101760. PubMed ID: 32203916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis.
    Seminary ER; Santarriaga S; Wheeler L; Mejaki M; Abrudan J; Demos W; Zimmermann MT; Urrutia RA; Fee D; Barkhaus PE; Ebert AD
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
    Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
    Okano H; Morimoto S; Kato C; Nakahara J; Takahashi S
    J Neurochem; 2023 Dec; 167(5):603-614. PubMed ID: 37952981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
    Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients.
    Bräuer S; Günther R; Sterneckert J; Glaß H; Hermann A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel protocol to derive cervical motor neurons from induced pluripotent stem cells for amyotrophic lateral sclerosis.
    Yang M; Liu M; Sánchez YF; Avazzadeh S; Quinlan LR; Liu G; Lu Y; Yang G; O'Brien T; Henshall DC; Hardiman O; Shen S
    Stem Cell Reports; 2023 Sep; 18(9):1870-1883. PubMed ID: 37595581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug screening for ALS using patient-specific induced pluripotent stem cells.
    Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
    Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
    Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
    Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects.
    Workman MJ; Lim RG; Wu J; Frank A; Ornelas L; Panther L; Galvez E; Perez D; Meepe I; Lei S; Valencia V; Gomez E; Liu C; Moran R; Pinedo L; Tsitkov S; Ho R; Kaye JA; ; Thompson T; Rothstein JD; Finkbeiner S; Fraenkel E; Sareen D; Thompson LM; Svendsen CN
    Neuron; 2023 Apr; 111(8):1191-1204.e5. PubMed ID: 36764301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons.
    Osaki T; Uzel SGM; Kamm RD
    Sci Adv; 2018 Oct; 4(10):eaat5847. PubMed ID: 30324134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.